HF
ZVSA

HRT Financial’s ZyVersa Therapeutics ZVSA Stock Holding History

HRT Financial’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,318
Closed -$9K – 3252
2024
Q1 		$9K Buy
+1,318
New +$9.93K ﹤0.01% 2077

Other funds holding ZVSA

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's ZVSA Position: Q2 2024 in Review

HRT Financial sold out of ZyVersa Therapeutics (ZVSA) in Q2 2024, closing a stake of 1,318 shares — an estimated $9K sold.

HRT Financial first reported a position in ZVSA in Q1 2024 and held it in 1 quarter. The position peaked at $9K in Q1 2024. 4 funds tracked by Wall St. Rank hold ZVSA as of Q2 2024.

  • HRT Financial reported no remaining ZyVersa Therapeutics position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 1,318 ZyVersa Therapeutics shares in Q2 2024, an estimated $9K.
  • HRT Financial first reported a position in ZyVersa Therapeutics in Q1 2024 and held it in 1 quarter.
  • HRT Financial's ZyVersa Therapeutics position peaked at $9K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.